Image Credit: Puwadol Jaturawutthichai/Shutterstock.com
Loaded Nanoparticles Temozolomide was first approved for use in the EU and United States in 1999 and has proven to be an effective treatment for treating malignant tumors when exposed to the site of treatment consistently. However, achieving this successfully is also one of the main challenges that medical professionals face.
Improving Brain Cancer Treatment Strategies Improving the ability to treat malignant glioblastomas is crucial as they are amongst the most aggressive and common forms of brain cancer with no known specific cause. In most cases, the chances are relatively high that patients will fall into remission due to the nature of these tumors and the limitations of current drug delivery systems.
Moreover, when treating their test animal models, the team discovered that the silica nanoparticles were able to reach the brain of the mice in just a few hours and had no negative impact on any other major organs in the body.